NX Development Corp. News & Updates

Catch our latest press releases, scientific updates, and company milestones.

April 24, 2025

qtq80-O3lkjw
Press Release

Sales and Marketing Rights of Gleolan® (aminolevulinic acid HCl) Return to NX Development Corp.

 

June 21, 2024

5ebB5so-1lsqhkkNQykTJ
Press Release

NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan®

March 5, 2024

qtq80-XlG3lE
Press Release

NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan® in Ovarian and Related Cancers